FINNENCE ▪ THE WIRE FILE
THE WIRE · № 70864
News■ Unclear/unknown
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES3
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 11:03 UTC
LAST UPDATE2026-10-08 11:03 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Veeva summit showcases AI in pharma R&D with named large-cap participants; promotional event notice without financials.
Life-sciences AI narrative, no hard data
CATALYST TO WATCH
Summit on October 20-21
MAIN RISK
Event marketing, no disclosed results
FULL DISPATCH
Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit on October 20-21 in Boston, Veeva Systems (NYSE:...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares AI
MINISFORUM Launches MS-S1 MAX-P495 with 192GB Unified Memory, Expanding Its Local AI Computing Strategy2026-10-08 11:07 UTC
MINISFORUM Launches MS-S1 MAX-P495 with 192GB Unified Memory, Expanding Its Local AI Computing Strategy2026-10-08 11:07 UTC
→CORRELATIONshares Healthcare
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy2026-10-08 11:30 UTC
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy2026-10-08 11:30 UTC
→CORRELATIONshares Healthcare
Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology2026-10-08 11:30 UTC
Hydreight Highlights U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Technology2026-10-08 11:30 UTC
→CORRELATIONshares Healthcare
Aragen Life Sciences begins Operations at OneHP, an Integrated High-potency Platform in Hyderabad, India2026-10-08 11:30 UTC
Aragen Life Sciences begins Operations at OneHP, an Integrated High-potency Platform in Hyderabad, India2026-10-08 11:30 UTC
→CORRELATIONshares Healthcare
Keenova Announces New Presentations at the Sexual Medicine Society of North America Annual Meeting2026-10-08 11:30 UTC
Keenova Announces New Presentations at the Sexual Medicine Society of North America Annual Meeting2026-10-08 11:30 UTC
→CORRELATIONshares Healthcare
Saol Therapeutics Announces Completion of Enrollment in Pivotal Phase III BEACON Trial of SL1002 for the Treatment of Chronic Pain Related to Osteoarthritis of the Knee2026-10-08 11:30 UTC
Saol Therapeutics Announces Completion of Enrollment in Pivotal Phase III BEACON Trial of SL1002 for the Treatment of Chronic Pain Related to Osteoarthritis of the Knee2026-10-08 11:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.